Wauwatosa, Wisconsin, and St. Louis, MO, March 25, 2025 (GLOBE NEWSWIRE) -- Splash Clinical, the new standard in trial enrollment, and C2N Diagnostics, LLC (“C2N”), a pioneer in advanced ...

The first-of-its-kind partnership combines Splash's recruitment platform with C2N's innovative blood tests to accelerate clinical research and improve patient experience. Wauwatosa, Wisconsin, and St.

Samsung C&T announced Thursday that its Life Science Fund, established in collaboration with Samsung Biologics, Samsung Bioepis and Samsung Venture Investment, will invest $10 million in C2N ...